Mycophenolate mofetil in a case of relapsed, refractory thrombotic thrombocytopenic purpura

A case of relapsing and refractory thrombotic thrombocytopenic purpura received mycophenolate mofetil (MMF) to attempt to maintain remission. The possible use of MMF in thrombotic thrombocytopenic purpura is discussed.

Saved in:
Bibliographic Details
Published inEuropean journal of haematology Vol. 78; no. 5; pp. 449 - 452
Main Authors Ahmad, Humayun N., Thomas‐Dewing, Rowena R., Hunt, Beverley J.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.05.2007
Subjects
Female
Humans
Immunosuppressive Agents - therapeutic use
Middle Aged
mycophenolate mofetil
Mycophenolic Acid - analogs & derivatives
Mycophenolic Acid - therapeutic use
Purpura, Thrombotic Thrombocytopenic - drug therapy
thrombotic thrombocytopenic purpura
Treatment Outcome
Online AccessGet full text

Cover

More Information
Summary:A case of relapsing and refractory thrombotic thrombocytopenic purpura received mycophenolate mofetil (MMF) to attempt to maintain remission. The possible use of MMF in thrombotic thrombocytopenic purpura is discussed.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0902-4441
1600-0609
DOI:10.1111/j.1600-0609.2007.00832.x